Analysis of pharmacist-provided Medication Therapy Management (MTM) services in community pharmacies over 7 years

Journal of Managed Care Pharmacy

Volumn 15, Issue 1, 2009, Pages 18-31

  Barnett, Mitchell J ^a   Frank, Jessica ^b   Wehring, Heidi ^a   Newland, Brand ^b   VonMuenster, Shannon ^a   Kumbera, Patty ^b   Halterman, Tom ^b   Perry, Paul J ^a  

^a TOURO UNIVERSITY CALIFORNIA   (United States)

^b Outcomes Pharmaceutical Health Care   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MACROLIDE; NARCOTIC ANALGESIC AGENT; NEUROLEPTIC AGENT; ORAL ANTIDIABETIC AGENT; PENICILLIN G; PROPRANOLOL; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; FEMALE; GASTROINTESTINAL DISEASE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MEDICARE; MEDICATION THERAPY MANAGEMENT; PARAMEDICAL PROFESSION; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACEUTICAL CARE; PHARMACIST; PRESCRIPTION; SYSTOLIC HEART FAILURE;

EID: 59849092853     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2009.15.1.18     Document Type: Article

References (17)

1. Public Law 108-173. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003, HR1. December 8, 2003. Available at: www.ustreas.gov/offices/public-affairs/hsa/pdf/pl108-173.pdf. Accessed November 27, 2008.
2. Centers for Medicare and Medicaid Services. Medicare Part D medication therapy management (MTM) programs - 2008 fact sheet. Available at: www.cms.hhs.gov/PrescriptionDrugCovContra/Downloads/MTMFactSheet.pdf. Accessed November 2, 2008.
3. Federal Register. Department of Health and Human Services. Centers for Medicare and Medicaid Services 2005;70(18):4193-742. Available at: www.edocket.access.gpo.gov/2005/pdf/05-1321.pdf. Accessed December 3, 2008.
4. Cameron KA. Comment on medication management models and other pharmacist interventions: implications for policy and practice. Home Health Care Serv Q. 2005;24:73-85.
5. American Pharmacists Association, National Association of Chain Drug Stores Foundation. Medication therapy management in community pharmacy practice: Core elements of an MTM service (Version 1.0). J Am Pharm Assoc. 2005;45:573-79.
6. Sound medication therapy management programs, version 2.0 with validation study. J Manag Care Pharm. 2008;14(1, S-b):S2-S42. Available at: www.amcp.org/data/jmcp/JMCPSuppB_Jan08.pdf
7. Bluml BM. Definition of medication therapy management: development of professionwide consensus. J Am Pharm Assoc. 2005;45:566-72.
8. Touchette DR, Burns AL, Bough MA, Blackburn, JC. Survey of medication therapy management programs under Medicare Part D. J Am Pharm Assoc. 2006;46:683-91.
9. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in project IMPACT: hyperlipidemia. J Am Pharm Assoc. 2000;40(2):157-65.
10. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: longterm clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173-84.
11. The Lewin Group. Medication Therapy Management services: a critical review. J Am Pharm Assoc. 2005;45:580-87.
12. Brewer J, Kumbera P. Establishing a Web-based program for reimbursement for medication therapy management services. Am J Health-Syst Pharm. 2006;63:1806-09.
13. Farris KB, Kumbera P, Halterman T, Fang, G. Outcomes-based pharmacist reimbursement: reimbursing pharmacists for cognitive services, part 1. J Manag Care Pharm. 2002;8(5):383-93. Available at: www.amcp.org/ data/jmcp/Contemporary%20Subjects-383-393.pdf.
14. Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med. 1995;155:1949-56.
15. Ernst FR, Grizzle AG. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001;41:192-99.
16. Stebbins MR, Kaufman DJ, Lipton, HL. The PRICE clinic for low-income elderly: A managed care model for implementing pharmacist-directed services. J Manag Care Pharm. 2005:11(4):333-41. Available at: www.amcp.org/data/jmcp/contemporary_333_341.pdf.
17. Kroner BA, Billups SJ, Garrison KM, Lyman AE, Delate T. Actual versus projected cost avoidance for clinical pharmacy specialist-initiated medication conversions in a primary care setting in an integrated health system. J Manag Care Pharm. 2008;14(2):155-63. Available at: www.amcp.org/data/jmcp/JMCPMaga_March%2008_155-163.pdf.